3006
CN:HYBRIBIO
凯普生物
- Stock
locale
Chinamarket
STOCKSindustry
Biotechnologywebsite
hybribio.cn/ipo date
Apr 13, 2017
Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatit...Show More